Issue date: February 2011.
"The guidance was developed using the NICE single technology appraisal process."
Publisher's number: N2448.
Bendamustine for the first-line treatment of chronic lymphocytic leukaemia by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2011. Publication and catalogue information, links to buy online and reader comments.